Moreover, a previous study with 5,889 Dutch BRCA1/2 mutation carriers showed that, compared to breast surveillance, BPM was associated with lower mortality for BRCA1 mutation carriers, whereas for BRCA2 mutation carriers breast cancer-specific survival rates were similar between BPM and breast surveillance [38]. This evidence concerns the gene BRCA1 and breast carcinoma.